Connect with us
Between the high cost and testing hurdles, molnupiravir may not be the “game changer” against COVID. Read More
What motivation science has to say about goodbyes. Plus, GE’s $1.45 billion acquisition and monoclonal antibody bottleneck. Read More
On the 20th anniversary of the September 11 World Trade Center attacks, America still hasn’t fulfilled its promises to EMTs and first responders. Read More
Employees and corporate offices could see a divide with customers with the CDC’s new indoor masking recommendation. Read More
Recent Comments